It is well accepted that events that interfere with the normal program of neuronal differentiation and brain maturation may be relevant for the etiology of psychiatric disorders, setting the stage for synaptic disorganization that becomes functional later in life. In order to investigate molecular determinants for these events, we examined the modulation of the neurotrophin brain-derived neurotrophic factor (BDNF) and the glutamate NMDA receptor following 24 h maternal separation (MD) on postnatal day 9. We found that in adulthood the expression of BDNF as well as of NR-2A and NR-2B, two NMDA receptor forming subunits, were significantly reduced in the hippocampus of MD rats whereas, among other structures, a slight reduction of NR-2A and 2B was detected only in prefrontal cortex. These changes were not observed acutely, nor in pre-weaning animals. Furthermore we found that in MD rats the modulation of hippocampal BDNF in response to an acute stress was altered, indicating a persistent functional impairment in its regulation, which may subserve a specific role for coping with challenging situations. We propose that adverse events taking place during brain maturation can modulate the expression of molecular players of cellular plasticity within selected brain regions, thus contributing to permanent alterations in brain function, which might ultimately lead to an increased vulnerability for psychiatric diseases.
Introduction
It has been long realized that experiences taking place early in life have a profound influence on brain development, produce persistent effects on its function while determining individual differences in the vulnerability to stress. 1, 2 Early work by Levine has clearly demonstrated that stimulation of neonatal rats affects their endocrine and behavioral responses later in life. 3 While brief, repeated manipulations (handling) may be beneficial in terms of stress reactivity and result in a more efficient coping with the environment, longer separations appear detrimental. [4] [5] [6] Accordingly adverse life events during the perinatal period produce permanent alterations at the level of hypothalamic-pituitaryadrenal (HPA) axis, which are accompanied by high anxiety-like behavior and age-related memory impairment. [7] [8] [9] Furthermore early adverse situations may increase the vulnerability to psychiatric disorders, such as depression and schizophrenia that, to some extent, can be characterized by altered regulation of the HPA axis and abnormal responses to stress. 10, 11 Hence if brain development is a key factor for disease susceptibility, the capability to reproduce alterations occurring early in life becomes crucial for animal modeling. Since mother-infant interaction may be a key factor for brain maturation and disease susceptibility, maternal deprivation (MD) represents a useful paradigm to study disturbances in brain function that might occur in response to adverse events during development.
Specifically, we investigated short-and long-term molecular changes taking place after a single 24 h MD on postnatal day 9 (pnd-9), a paradigm that recapitulates several features of schizophrenia. 12 Although different factors may be important for the derangement in brain development, we reasoned that early adverse life events could produce long-lasting impairment in brain function through changes in important modulators of synaptic plasticity. The present study tested this hypothesis through the analysis of the neurotrophin brain derived neurotrophic factor (BDNF) and the glutamate N-methyl-D-aspartate (NMDA) receptor. Changes in neurotrophin levels as well as in the expression of this glutamate receptor subtype have Molecular Psychiatry been recently documented in psychiatric patients, pointing to a potential contribution in schizophrenic pathology and/or etiology. [13] [14] [15] [16] BDNF can affect neuronal survival and differentiation 17 and, together with the NMDA receptor complex, play a role as mediators of activity-dependent brain plasticity as well as in spatial learning and memory. [18] [19] [20] [21] [22] We have therefore analyzed the expression of these elements in pre-weaning and adult MD rats, as well as the levels of BDNF in adult animals in response to an acute challenging situation in order to evaluate whether the stress-dependent regulation of neurotrophin production could be altered as a consequence of early exposure to MD.
Materials and methods

Materials
General reagents were purchased from Sigma (Milan, Italy), whereas molecular biology reagents were obtained from Ambion (Austin, TX, USA), New England Biolabs (Beverly, MA, USA) and Promega (Milan, Italy).
Animals and maternal deprivation
Male and nulliparous female Wistar rats of 3 months old were put together in standard Macrolon cages with sawdust (26 × 42 × 15 cm), in temperature-controlled rooms (23 ± 1°C). The rats were on a standard 12 h light/dark cycle with light on from 7.00 to 19.00 h, with water and food freely available. Two weeks later the males were removed from the cages and females were checked twice daily for delivery (08.00 and 17.00 h). The day of delivery was denoted as pnd 0. On pnd 1 the litters were weighed and culled to six males and two females. Maternal deprivation took place on pnd 9 according to our standard procedure. 12 In brief, the mothers were removed at 10.00 h, after which the pups were weighed and returned to their homecages. They remained in their homecage at room temperature for 24 h. On pnd 10, the pups were weighed again and the mothers returned to their cages. The mothers of the control litters were briefly removed from their homecages and the pups were weighed both on pnd 9 and pnd 10. Weaning took place at pnd 21, where rats were normally housed in groups of three males and two females per cage. All the determinations were carried out on male rats.
Stress experiment
The effect of acute stress on BDNF gene expression was assessed in adult sham or MD animals (pnd 72). Rats were randomly assigned to four groups (control, no MD/no stress; no MD/stress; MD/no stress; MD/stress). The animals undergoing restraint stress were placed for 2 h in transparent plexiglass containers whereas those in the 'no-stress' group were left undisturbed in their home cages. Rats were killed by decapitation 1 h after the end of immobilization. Following death most brain regions were rapidly dissected from 2-mm thick slices according to the atlas of Paxinos and Watson, 23 as previously described. 24 The brain specimens were frozen on dry ice and stored at −80°C for further analysis.
RNA preparation
Brain tissue was homogenized in 4 M guanidinium isothiocyanate (containing 25 mM sodium citrate pH 7.5, 0.5% sarcosyl and 0.1% 2-mercaptoethanol) and total RNA was isolated by phenol-chloroform extraction according to standard procedures. Quantification was carried out by spectrophotometric analysis and RNA aliquots were re-precipitated in ethanol for RNase protection assay.
RNA probes synthesis and RNase protection assay
A transcription kit (MAXI script, Ambion) was used to generate cRNA probes and 32 P-CTP was used as a radiolabelled nucleotide. The cRNA probes and the relative protected fragment (p.f.) were the following: BDNF = 800, p.f. = 740; Trk-B = 507, p.f. = 447; NR-1 = 438, p.f. = 414; NR-2A = 187, p.f. = 171; NR-2B = 310, p.f. = 264; GAPDH (pTRI-GAPDH-Rat, Ambion) = 376, p.f. = 316. The cRNA probes for NMDA receptor subunits have been previously characterized for their specificity and used for the simultaneous detection of their mRNA levels in rat brain regions. 25 We used 150 000 cpm per sample of the 32 P-labeled cRNA to BDNF, NR-2B and NR-2A, and 50 000 cpm per sample of the 32 P-labeled cRNA to Trk-B, NR-1 or GAPDH. The RNase protection assay was performed on a 10 g sample of total RNA as described previously. 24 Briefly, after ethanol-precipitation, total RNA was resuspended in 20 l of hybridization solution (80% formamide, 40 mM PIPES pH 6.4, 400 mM sodium acetate pH 6.4 and 1 mM EDTA) containing different 32 P-labeled cRNA probes. Samples were hybridized at 45°C overnight. At the end of the hybridization, the solution was diluted with 200 l of RNase digestion buffer containing a 1/200 dilution of a RNase cocktail (1 mg ml
RNase A and 20 U ml −1 RNase T1) and incubated for 30 min at 30°C. Proteinase K (10 g) and SDS (10 l of 20% stock solution) were then added to the sample and the mixture was incubated at 37°C for an additional 15 min. At the end of the incubation the sample was extracted with phenol/chloroform and ethanol precipitated. The pellet, containing the RNA:RNA hybrids, was dried and resuspended in loading buffer, boiled at 95°C for 5 min and separated on a 5% polyacrylamide gel under denaturing conditions (7 M urea). The protected fragments were visualized by autoradiography.
Analysis of protein levels
The hippocampus of control or MD animals was homogenized in lysis buffer (137 mM NaCl, 20 mM Tris, 1% NP-40 detergent, 10% glycerol, 1 mM methylphenylsulfonylfluoride, 10 g ml −1 aprotinin, 1 g ml
leupeptin and 0.5 mM sodium orthovanadate).
Homogenates were centrifuged at 16 000 g for 30 min in a cold room and supernatants were used for ELISA analysis. The BDNF or NT-3 Emax ImmunoAssay system (Promega) was used to measure BDNF or NT-3 protein levels in hippocampus according to the manufacturer's protocol.
RNA calculation and statistical analysis
The levels of mRNA for BDNF, Trk-B, NMDA-R subunits or GAPDH were calculated using the Quantity One software from Biorad. In order to ensure that the autoradiographic bands were in the linear range of intensity, different exposure times were used. GAPDH was employed as internal standard for RNase protection assay: its expression was not altered by MD or by stress. Optical densities from experimental groups were then expressed and presented as mean percent of control values for graphic clarity. The mean percent represents the ratio between BDNF, Trk-B or NMDA-R subunits and GAPDH levels expressed as % of control animals. The mean value of the control group within a single experiment was set to 100 and all other values were expressed as 'percent' of control animals. Changes produced by MD on BDNF or NMDA-R subunits in different brain regions, at different ages, were analyzed by one-way analysis of variance (ANOVA). Significant changes were determined by Dunnett's test. The results of the acute stress experiment were analyzed by two-way analysis of variance (ANOVA), with status (sham and MD) and treatment (no stress and stress) as independent factors and BDNF levels as dependent variables. When appropriate, further differences were analyzed by Single Contrast post-hoc test (SCPHT).
Results
The expression of the neurotrophin BDNF was analyzed in adult animals that experienced a single 24 h MD on pnd-9. Figure 1a shows a representative RNase Figure 1 Effect of maternal deprivation (24 h on pnd-9) on BDNF mRNA levels in the adult rat brain. (a) RNase protection analysis of BDNF mRNA levels in the hippocampus of control (CTRL) or maternal deprived (MD) adult rats. Arrows indicate the protected fragments for BDNF or GAPDH, used as internal standard. The autoradiographic film was exposed at −70°C with an intensifying screen for 5 h (GAPDH) or 18 h (BDNF). (b) The levels of BDNF mRNA in different brain regions are expressed as the percentage of change in MD rats with respect to control animals. Each value is the mean ± SEM of 8-12 independent determinations in the following brain regions: HIP, hippocampus; PFC, prefrontal cortex; FC, frontal cortex; PIR, piriform cortex; PC, parietal cortex; THA, thalamus; NA, nucleus accumbens. *PϽ0.01 vs control animals (one-way ANOVA with Dunnett t-test).
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protection assay for the analysis of BDNF mRNA levels in the hippocampus of control or MD adult rats. We observed a significant reduction of the mRNA levels for BDNF in the hippocampus of MD animals ( Figure 1b ) with no changes in the expression of its high affinity receptor Trk-B (Control = 100 ± 9; MD = 103 ± 11). This effect is rather specific from the anatomical point of view, since no significant changes were detected in other brain structures, including cortical regions (prefrontal, frontal, piriform and parietal) as well as thalamus and nucleus accumbens (Figure 1b) . The downregulation of BDNF mRNA was accompanied by a significant decrease of its protein levels (−32 ± 6% of controls), whereas the expression of another neurotrophin, NT-3, was not altered in the hippocampus of MD rats (Figure 2) .
Since it is known that stress can modulate the expression of BDNF, 26 we investigated if the changes observed within the hippocampus represent the result of the acute deprivation. However the reduction of hippocampal BDNF appears to be a long-term consequence of the early events since, as shown in Figure 3 , the mRNA levels for BDNF and Trk-B were not changed 2, 6 or 24 h after the deprivation on pnd-9. Furthermore the expression of the neurotrophin and its receptor was also unchanged on pnd-21 ( Figure 3) .
As MD during early postnatal life produces persistent changes in the stress response, 27, 28 we decided to investigate the expression of BDNF under a challenging situation in adult animals. For this reason control and MD rats were exposed to a single 2 h restraint stress, a procedure known to reduce BDNF levels in the hippocampus. 26 We observed a significant effect of MD on stress-induced modification of BDNF mRNA levels in adult animals. In fact the decrease of BDNF mRNA expression after immobilization was significant in Figure 2 Analysis of BDNF and NT-3 protein levels in the hippocampus of adult control or MD rats. The data represent the mean ± SEM of at least six independent determinations for each experimental group. *PϽ0.05 vs control animals (one-way ANOVA with Dunnett t-test).
Figure 3
Time course analysis of the changes in hippocampal mRNA levels for BDNF and its high affinity receptor Trk-B following MD. Animals were killed either 2, 6 or 24 h after removal of the mother (pnd-9/10) or they were killed on pnd-21 after 24 h MD on pnd-9. The results, expressed as % of change with respect to control rats, represent the mean ± SEM of 5-8 samples for each experimental group.
sham (F 1,28 = 17.016, P = 0.001; SCPHT) but not in MD rats (F 1,28 = 0.275, P = 0.603; SCPHT) (Figure 4) , suggesting that in these animals the stress-dependent regulation of BDNF was significantly altered.
Glutamate is one of the neurotransmitters that regulates the expression of BDNF. 29, 30 We have therefore investigated, under the same experimental paradigm, the expression of the subunits for the glutamate NMDA receptor (NR), a system involved in activity-dependent plasticity of the hippocampus, which can also be a tar- get for short-term modification of synaptic function by neurotrophins. 21, 31 As adults, MD rats display a significant reduction of hippocampal NR-2A and NR-2B subunit expression, while no changes were observed in the mRNA levels for NR-1 (Figure 5a and b) . As shown for BDNF, this effect appears to be quite specific for this brain region, although a similar, but not significant reduction in the expression of NR-2A and -2B subunits was observed in prefrontal cortex (but not in other structures). Furthermore the temporal occurrence of the changes in hippocampal NMDA receptor subunits matches those on BDNF, as no modifications of NR-2A and NR-2B mRNA levels were evident in preweaning rats (Table 1) .
Discussion
The present results demonstrate that a single 24 h MD on pnd-9 produces a persistent reduction in the expression of the neurotrophin BDNF as well as of the glutamate NMDA receptor subunits NR-2A and NR-2B in rat hippocampus and, to lesser extent, in cortical areas. Our results point to the fact that variations in maternal care not only influence the development of behavior and endocrine responses to stress in the offspring, 1, 5, 6 but determine alterations in molecular players of cellular plasticity. These effects are specific from the anatomical and temporal point of view and might represent one of the mechanisms through which early adverse life events determine long-term impairment in brain function and plasticity.
Several years ago Levine showed that the development of the HPA axis response to stress is modified by early environmental events. 3 It is well established that neonatal handling or high maternal care determines a reduction of ACTH and corticosterone response to stress, 6 whilst adverse life events during early development enhance the HPA axis activity. 27 The effects we 
Group
NR-1 NR-2A NR-2B (% of control levels)
Control 100 ± 6 100 ± 10 100 ± 6 MD 108 ± 3 9 9± 6 108 ± 5 report display a rather selective anatomical specificity for the hippocampus, since less consistent changes in the expression of BDNF and NR-2A/2B were observed only in frontal and prefrontal cortex. The hippocampus undergoes an experience-dependent development and its maturation extends into the first 3 weeks of postnatal life, suggesting that the time of deprivation coincides with an active synaptogenesis at this level. Moreover high levels of glucocorticoid receptors (GR) are present in the hippocampus, where they mediate feedback control on the HPA axis as well as contribute to the vulnerability of this region to stress-related events. 32 A balanced supply of corticosteroids appears to be important for hippocampal integrity since chronic elevation of corticosteroid as well as adrenalectomy can lead to degeneration of specific cellular phenotypes within the hippocampal formation. 33, 34 Liu et al have recently reported that high maternal Molecular Psychiatry care, a situation that can be considered the opposite with respect to MD, favors hippocampal plasticity and enhances spatial learning and memory through the upregulation of BDNF and NMDA-R subunits. 35 However while the changes of the neurotrophin expression they report are evident on pnd-8, but not in adulthood, 24 h MD produces a reduction of BDNF mRNA and protein only in adult animals. In fact modifications in the neurotrophin biosynthesis were observed neither 2, 6 nor 24 h after acute MD nor in pre-weaning rats (pnd-21), suggesting that the changes in its expression may represent the long-term consequence of developmental abnormalities, rather than being a short-term effect of the deprivation. We argue that 24 h MD may interfere with hippocampal maturation and this may lead to a reduction of BDNF levels in adulthood as a consequence of changes in neurotransmitters or hormones involved in the control of the neurotrophin production.
The modulation of BDNF levels is somewhat different from what we have previously observed using another paradigm, namely the hippocampal lesion with ibotenic acid on pnd-7. This animal model, similarly to 24 h MD, reproduces schizophrenia-like dysfunction that, at least in part, is ameliorated by exposure to antipsychotic drugs. 36 We found that, in adulthood, animals lesioned with ibotenic acid have reduced basal levels of BDNF mRNA in cingulate cortex as well as alterations in its acute modulation within the prefrontal cortex. 24 This suggests that damage of the hippocampus during the late stage of maturation may affect regions that are targets of hippocampal output, Molecular Psychiatry whereas stress-related events during early postnatal life have a stronger and more selective impact over the hippocampus itself. A common element in these two paradigms is represented by the emergence of BDNF abnormalities after puberty, which is consistent with a major feature of schizophrenia 37 and corresponds to the post-pubertal development of other schizophreniarelated abnormalities in both experimental models. 12, 38 This suggests that a latency does occur between the adverse events and the full manifestation of impairment in cellular plasticity.
It is known that BDNF exerts an important role in synaptic transmission and plasticity within the hippocampus. 18, 21, 22, 39 Its expression is regulated by neuronal activity 40, 41 and the neurotrophin can modulate synaptic function at different levels. 18 Application of exogenous BDNF facilitates hippocampal long-term potentiation (LTP), whereas animals with impaired expression of BDNF display defects in LTP and learning. 42 This functional abnormality may depend upon impairment in neurotransmitter release, since heterozygous (+/-) BDNF mice display a significant reduction of the vesicles docked at presynaptic active zones, as well as a reduction of synaptobrevin and synaptophysin, two proteins involved in vesicle docking and fusion. 43 Interestingly it has been reported that the upregulation of BDNF associated with high maternal care is paralleled to a significant increment in the expression of synaptophisin. 35 It may therefore be inferred that a reduction in the expression of neurotrophin in MD animals could lead to an impairment in neurotransmitter secretion and a functional reduction in activity-dependent processes.
The reduction in the expression of hippocampal BDNF after MD may also increase the vulnerability of this region under challenging situations. BDNF is highly protective for different neuronal phenotypes and can prevent neuronal cell death in different experimental paradigms in vivo as well as in vitro. 44, 45 Endogenous production of BDNF is essential for the survival and maturation of cortical neurons in vitro 46 and can also support cell sprouting after striatal injury. 47 Conversely, environmental enrichment produces an upregulation of hippocampal BDNF expression, which is protective against spontaneous apoptotic cell death and kainate-induced degeneration. 48 All together these data point to an important role for endogenously expressed BDNF and its acute modulation, in setting the vulnerability threshold of specific cellular phenotypes. A reduction of its biosynthesis could therefore be of relevance in situations, such as stress, which imply the elaboration of effective coping strategies.
Furthermore our results indicate that MD induced a persistent change in the mechanisms involved in the acute modulation of BDNF. In fact, the downregulation of neurotrophin expression in control animals following an acute restraint stress was not observed in rats that have been exposed to MD on pnd-9. Since MD reduces GR expression in the hippocampus, 27 the initial response to stress (in terms of BDNF modulation) may be reduced. However an impaired feedback control on the HPA axis will lead to a prolonged elevation of circulating corticosterone that, in turn, might determine a more protracted reduction of BDNF expression. In this respect Biagini et al have shown that repeated MD from pnd 2 to 6 leads to higher corticosterone release and lower hippocampal GR immunoreactivity after novelty. 49 Accordingly we have recently found that short-term exposure to corticosterone during late gestation, decreases BDNF biosynthesis and produces a less prominent but more protracted reduction of its expression after an acute restraint stress (Molteni and Riva, unpublished observations). Although 'speculative', these data suggest that a 'worsening' in the modulation of the neurotrophin might occur at later time points, particularly under enduring exposure to stress. This will ultimately lead to an increased vulnerability, which might recapitulate what is taking place during the course of psychiatric illnesses. The impairment in the acute modulation of BDNF may also be detrimental for the performance of specific functional tasks, which are regulated by the neurotrophin. A rapid and selective induction of BDNF does indeed occur in the hippocampus during contextual learning in rats 50 as well as in the inferior temporal cortex of monkey during declarative memory formation. 51 This suggests that a reciprocal modulation between BDNF and synaptic function exists and that the proper control of neurotrophin production may be important for activity-dependent plasticity.
The reduction of hippocampal BDNF expression after MD may, at least in part, be related to the glutamate NMDA receptor, which can be a target for shortterm effects of BDNF on synaptic plasticity, 21, 31 but can also operate in the modulation of BDNF expression. 29, 30 Indeed there is a close resemblance in the temporal and anatomical pattern of the changes for NR-2A and NR-2B subunits, which occur in the hippocampus, and to lesser extent in prefrontal cortex, of adult MD rats. The NMDA receptor is a heteromeric complex consisting of subunit 1 (NR-1) and 2 (NR-2 A, B, C and D). 52 Genetic (NR-1 knock-down mice) and pharmacological (phencyclidine) manipulations of the glutamate NMDA receptor reproduce some of the deficits observed in schizophrenia 53, 54 and abnormalities in the expression of this glutamate receptor subtype have been reported in the brain of schizophrenic subjects. 15, 16 In line with the well-established role of glutamate NMDA receptors in learning and memory, 55 high maternal care upregulates the expression of different NMDA receptor subunits in the hippocampus of developing and adult animals, while determining an improvement in cognitive activity. 35 Hence a reduction of NR-2A and NR-2B subunits, in conjunction with BDNF, might not only reduce brain plasticity but also determine a decline in cognitive function, which represents a major feature of schizophrenia-related disorders. Accordingly, Oitlz and coworkers have shown that 24 h MD on pnd-3 produces cognitive impairment throughout life, 9 whereas prenatal stress has a stronger impact on the cognitive performance of aged rats. 7 Taken together, our data suggest that a reduction of BDNF and NMDA-R subunit expression can contribute to long-term impairment in brain function following early life stress. This provides a rationale for developing novel therapeutic strategies aimed to reestablish the function of these modulators for treating disorders, such as depression and schizophrenia, which might be characterized by a reduction in cellular plasticity.
